Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03087942
What this trial is testing

Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects

Who this might be right for
Renal Insufficiency
Novartis Pharmaceuticals 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715216
What this trial is testing

EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 23
Early research (Phase 1)Ended earlyNCT03947814
What this trial is testing

Orally Administered Pimodivir in Adult Participants With Renal Impairment

Who this might be right for
Kidney Failure, Chronic
Janssen-Cilag International NV 29
Not applicableUnknownNCT03175848
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer

Who this might be right for
Cervical Cancer Stage IVB
Zhejiang Cancer Hospital 48
Not applicableNo Longer AvailableNCT03801278
What this trial is testing

An Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder Cancer

Who this might be right for
Recurrent Bladder Cancer
Five Prime Therapeutics, Inc.
Large-scale testing (Phase 3)Ended earlyNCT00821184
What this trial is testing

Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder

Who this might be right for
Overactive Bladder
Lahey Clinic 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07368985
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Who this might be right for
Cervical Cancer by FIGO Stage 2018Squamous Cell Carcinoma FIGO 2018 Stage IIIA, IIIB, IIIC1-IIIC2Adenocarcinoma or Adeno-squamous Carcinoma Stage IB3-IIIC2
Prof. Dr. Remi A. Nout 87
Testing effectiveness (Phase 2)Looking for participantsNCT07594106
What this trial is testing

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals 265
Early research (Phase 1)Ended earlyNCT02508740
What this trial is testing

Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment

Who this might be right for
Renal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 31
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Not applicableWithdrawnNCT00956176
What this trial is testing

Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis

Who this might be right for
CystitisBladder Diseases
M.D. Anderson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT02496208
What this trial is testing

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more
National Cancer Institute (NCI) 152
Not applicableActive Not RecruitingNCT05279560
What this trial is testing

Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation

Who this might be right for
Premature Ovarian InsufficiencyInfertility, FemaleSterility, Female+1 more
University of Luebeck 114
Testing effectiveness (Phase 2)Study completedNCT03558503
What this trial is testing

A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 63
Not applicableLooking for participantsNCT06558682
What this trial is testing

Neoadjuvant Therapy in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Qilu Hospital of Shandong University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06771596
What this trial is testing

Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix

Who this might be right for
Uterine Cervical Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43
Testing effectiveness (Phase 2)Study completedNCT02736305
What this trial is testing

Use of Regorafenib in Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
National Cancer Centre, Singapore 21
Large-scale testing (Phase 3)Active Not RecruitingNCT04241185
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

Who this might be right for
Urinary Bladder Neoplasms
Merck Sharp & Dohme LLC 520
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Next Page